Pipeline as of 2019 with expected approval dates

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
frodo
Family Elder
Posts: 1355
Joined: Wed Dec 02, 2009 3:00 pm
Contact:

Pipeline as of 2019 with expected approval dates

Post by frodo » Fri Dec 21, 2018 6:16 am

I have found this PDF with the new medications and the expected realease date. Most of them in 2020 (in the states) but some in 2019

https://www.ptcommunity.com/system/file ... 312750.pdf

Siponimod: 2019
Ozanimod: 2019
Ofatumumab (Arzerra): 2020
Ponesimod: 2020
Masitinib: 2020
MD1003: 2020
Ublituximab: 2022

Updates:

Siponimod was approved in march 2019.
Ozanimod:
- Submited to FDA, May 2019 (https://ir.celgene.com/press-releases/p ... fault.aspx)
- Submission accepted in June (https://ir.celgene.com/press-releases/p ... fault.aspx)

Post Reply
  • Similar Topics
    Replies
    Views
    Last post